Top Markets
Coin of the day
Eucrates Biomedical Acquisition Corp. Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.

EUCR
Rank in Stocks #26003
Eucrates Biomedical Acquisition Corp. currently lacks substantial business... Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity acquisition, restructuring, or another comparable strategic alliance involving one or more enterprises. Specifically, it aims to find and acquire a company operating within the life sciences or broader healthcare sectors across North America and Europe. Established in 2020, this entity has its headquarters situated in New York, New York.
Share Price
$10.04
Last synced: 2023-05-05
Market Cap
$44.29M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Eucrates Biomedical Acquisition Corp. (EUCR)
P/B ratio for Eucrates Biomedical Acquisition Corp. (EUCR)
P/B ratio as of 2026 TTM: 0
According to Eucrates Biomedical Acquisition Corp. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Eucrates Biomedical Acquisition Corp. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors